336 related articles for article (PubMed ID: 26211568)
1. Approaches to treatment 1: How is type 2 diabetes actually treated?
Bloomgarden ZT
J Diabetes; 2015 Nov; 7(6):747-8. PubMed ID: 26211568
[No Abstract] [Full Text] [Related]
2. Contemporary National Patterns of Eligibility and Use of Novel Cardioprotective Antihyperglycemic Agents in Type 2 Diabetes Mellitus.
Nargesi AA; Jeyashanmugaraja GP; Desai N; Lipska K; Krumholz H; Khera R
J Am Heart Assoc; 2021 Jul; 10(13):e021084. PubMed ID: 33998258
[TBL] [Abstract][Full Text] [Related]
3. Patterns and trends in insulin intensification among patients with type 2 diabetes: a systematic review.
Polinski JM; Connolly JG; Curtis BH; Seeger JD; Gaskins K; Perez M; Smith BF; Shrank WH
Prim Care Diabetes; 2014 Jul; 8(2):101-9. PubMed ID: 24275103
[TBL] [Abstract][Full Text] [Related]
4. Initial treatment of diabetes in Italy. A nationwide population-based study from of the ARNO Diabetes Observatory.
Bonora E; Cataudella S; Marchesini G; Miccoli R; Vaccaro O; Fadini GP; Martini N; Rossi E;
Nutr Metab Cardiovasc Dis; 2021 Aug; 31(9):2661-2668. PubMed ID: 34218990
[TBL] [Abstract][Full Text] [Related]
5. Assessing variability in compliance with recommendations given by the International Diabetes Federation (IDF) for patients with type 2 diabetes in primary care using electronic records. The APNA study.
Brugos-Larumbe A; Aldaz-Herce P; Guillen-Grima F; Garjón-Parra FJ; Bartolomé-Resano FJ; Arizaleta-Beloqui MT; Pérez-Ciordia I; Fernández-Navascués AM; Lerena-Rivas MJ; Berjón-Reyero J; Jusué-Rípodas L; Aguinaga-Ontoso I
Prim Care Diabetes; 2018 Feb; 12(1):34-44. PubMed ID: 28732655
[TBL] [Abstract][Full Text] [Related]
6. Changes in the management of type 2 diabetic patients in family medicine practices in the Bursa region.
Göktaş O; Öz Gül Ö; Ertürk E
Prim Care Diabetes; 2017 Apr; 11(2):178-183. PubMed ID: 27852516
[TBL] [Abstract][Full Text] [Related]
7. Mismatch between ADA and AGS recommendations for glycated hemoglobin targets for older adults.
Tasci I; Safer U; Naharci I; Sonmez A
Prim Care Diabetes; 2018 Apr; 12(2):192-194. PubMed ID: 29396204
[TBL] [Abstract][Full Text] [Related]
8. Employing observational method for prospective data collection: A case study for analyzing diagnostic process and evaluating efficacy of TCM treatments for diabetes mellitus.
Gu X; Huang N; Gu J; Joshi MK; Wang H
J Ethnopharmacol; 2016 Nov; 192():516-523. PubMed ID: 27616025
[TBL] [Abstract][Full Text] [Related]
9. American Diabetes Association Standards of Medical Care in Diabetes 2017.
Marathe PH; Gao HX; Close KL
J Diabetes; 2017 Apr; 9(4):320-324. PubMed ID: 28070960
[No Abstract] [Full Text] [Related]
10. Are We There Yet?
Tsai A
Diabetes Forecast; 2016; 69(1):52-7. PubMed ID: 26983288
[No Abstract] [Full Text] [Related]
11. Initial therapy, persistence and regimen change in a cohort of newly treated type 2 diabetes patients.
Grimes RT; Bennett K; Tilson L; Usher C; Smith SM; Henman MC
Br J Clin Pharmacol; 2015 Jun; 79(6):1000-9. PubMed ID: 25521800
[TBL] [Abstract][Full Text] [Related]
12. Geographic Variation in Rosiglitazone Use Surrounding FDA Warnings in the Department of Veterans Affairs.
Ahuja V; Sohn MW; Birge JR; Syverson C; Budiman-Mak E; Emanuele N; Cooper JM; Huang ES
J Manag Care Spec Pharm; 2015 Dec; 21(12):1214-34. PubMed ID: 26679970
[TBL] [Abstract][Full Text] [Related]
13. Adherence to national diabetes guidelines through monitoring quality indicators--A comparison of three types of care for the elderly with special emphasis on HbA1c.
Neumark AS; Brudin L; Neumark T
Prim Care Diabetes; 2015 Aug; 9(4):253-60. PubMed ID: 25865853
[TBL] [Abstract][Full Text] [Related]
14. Trends in the prescription of anti-diabetic medications in the United Kingdom: a population-based analysis.
Filion KB; Joseph L; Boivin JF; Suissa S; Brophy JM
Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):973-6. PubMed ID: 19621344
[TBL] [Abstract][Full Text] [Related]
15. Comparison of physician practice patterns for older adults compared to NHANES diabetes cohort on oral/other therapy.
Shaya FT; Chirikov VV; Bron M; Howard D; Foster C; Yan X; Khanna N; Warrington VO
Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):153-60. PubMed ID: 23402455
[TBL] [Abstract][Full Text] [Related]
16. Gaps and barriers in the control of blood glucose in people with type 2 diabetes.
Blonde L; Aschner P; Bailey C; Ji L; Leiter LA; Matthaei S;
Diab Vasc Dis Res; 2017 May; 14(3):172-183. PubMed ID: 28467203
[TBL] [Abstract][Full Text] [Related]
17. Diabetes: Time for reconciliation between cardiologists and diabetologists.
Scheen AJ
Nat Rev Cardiol; 2016 Sep; 13(9):509-10. PubMed ID: 27411401
[No Abstract] [Full Text] [Related]
18. Guidelines and clinical practice at the primary level of healthcare in patients with type 2 diabetes mellitus with and without kidney disease in five European countries.
Eder S; Leierer J; Kerschbaum J; Rosivall L; Wiecek A; de Zeeuw D; Mark PB; Heinze G; Rossing P; Heerspink HL; Mayer G
Diab Vasc Dis Res; 2019 Jan; 16(1):47-56. PubMed ID: 30238781
[TBL] [Abstract][Full Text] [Related]
19. Achievement of recommended glucose and blood pressure targets in patients with type 2 diabetes and hypertension in clinical practice - study rationale and protocol of DIALOGUE.
Gitt AK; Schmieder RE; Duetting E; Bramlage P; Schneider S; Tschöpe D;
Cardiovasc Diabetol; 2012 Dec; 11():148. PubMed ID: 23216660
[TBL] [Abstract][Full Text] [Related]
20. Patterns of glucose lowering drugs utilization in Portugal and in the Netherlands. Trends over time.
Torre C; Guerreiro J; de Oliveira Martins S; Raposo JF; Martins AP; Leufkens H
Prim Care Diabetes; 2015 Dec; 9(6):482-9. PubMed ID: 25911273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
